NAMSA and NAGLREITER Partner to Provide Innovative Development Solution to Global Medical Device Manufacturers

In Press Release by Leah Davidson

TOLEDO, Ohio & FT. LAUDERDALE, Fla.–(BUSINESS WIRE)–NAMSA®, the world’s only Medical Research Organization (MRO®) that accelerates medical device development through integrated laboratory, clinical and consulting services, is pleased to announce its partnership with NAGLREITER™ Medical Device Development Organization (MDDO), a high-growth medical device design, development and manufacturing firm.

For nearly 50 years, NAMSA has focused on offering the most critical services required to accelerate time-to-market and reduce costs for medical device research clients across the world. Consistently recognized as a pioneer in medical device development – most recently with the honor of the “CRO Leadership Award,” presented by Life Science Leader magazine – NAMSA has a proven and established track record of delivering expedited results through the utilization of its translational research methods.

NAGLREITER, similarly placing a significant concentration on providing efficacious customer outcomes, applies an integrated approach within its design, development and manufacturing service offerings. Providing end-to-end solutions for over 20 years, NAGLREITER focuses on technical and design alternatives that reduce costs and fast-track timelines that move clients into device production as quickly as possible.

This partnership, drawing upon a combined 70 years’ experience in assisting thousands of customers to successfully commercialize products throughout the world, will now provide early-stage medical device firms a single source, power house solution through its combined full service offering.

John Amat, NAMSA’s Chief Commercial Officer, said in support of the collaboration, “We are extremely excited about this unique partnership that will result in more predictable development timelines, increased cost savings and unparalleled time-to-market for device firms. NAGLREITER’s ‘Product Lifecycle Management’ methodology of innovation perfectly complements NAMSA’s ‘MRO Approach.’ Together, we will be able to more effectively drive start-up device programs and appropriately address the challenges and risks that these organizations face due to fragmented resources and increasingly complicated regulatory landscapes.”

President of NAGLREITER, Brett Naglreiter, also commenting on the collaboration, stated, “NAGLREITER’s year-over-year success has opened up this exclusive opportunity to join forces with the leader in global medical device research. We fully expect our partnership to provide customers with further efficiencies that result from having access to a comprehensive portfolio of development resources and commercialization services that are managed through a single source.”

NAMSA and NAGLREITER look forward to providing early-stage medical device organizations with a unique, world-class solution that will allow them to bring life-changing therapies to the marketplace in the most efficient manner possible.

Medical device firms wishing to learn more about this partnership program may contact us at or (866) 666-9455.


NAMSA is the world’s only Medical Research Organization (MRO) that accelerates medical device product development through integrated laboratory, clinical and consulting services. Driven by our regulatory expertise, NAMSA’s MRO® Approach plays an important role in translational research, applying a unique combination of disciplines – consulting, regulatory, preclinical, toxicology, microbiology, chemistry, clinical and quality – to move clients’ products through the development process, and continue to provide support through commercialization to post-market requirements, anywhere in the world.

Follow us on TwitterLinkedIn or Facebook for regular updates.


NAGLREITER Medical Device Development Organization (MDDO) is a trusted partner for concept incubation, design, development and manufacturing engineering services within the Medtech industry. NAGLREITER prides itself on providing world-class services and employing a uniquely flexible business model to do so. NAGLREITER’s ‘The Right Path. With You’ business philosophy exemplifies the company’s commitment to partnering with clients in any way they require to yield the best possible outcomes. Based in the Ft. Lauderdale area in Miramar, Florida, NAGLREITER partners with medical device companies within the U.S. and abroad.


NAMSA Contact:
Leah Davidson, 612-615-6985
Manager, Marketing Communications 


Lance Perkins, 954-415-3090
Vice President, Marketing and SAles 

Leah Davidson

Leah serves as NAMSA's Marketing Communications Manager and brings 20 years of marketing communications experience within the medical device and healthcare technology industries. In her role, she is responsible for the development and implementation of brand strategies and marketing communications initiatives that help drive NAMSA’s sales and organizational growth goals globally. Leah holds a Bachelor's Degree and a Masters of Business Administration from Hamline University (St. Paul), as well as a Masters of Nonprofit Management from Concordia University-St. Paul.